140 related articles for article (PubMed ID: 32205472)
1. Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.
Ho YC; Ahuja KDK; Andrews RK; Adams MJ
Blood Coagul Fibrinolysis; 2020 Jun; 31(4):258-263. PubMed ID: 32205472
[TBL] [Abstract][Full Text] [Related]
2. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
Al-Tamimi M; Grigoriadis G; Tran H; Paul E; Servadei P; Berndt MC; Gardiner EE; Andrews RK
Blood; 2011 Apr; 117(14):3912-20. PubMed ID: 21252089
[TBL] [Abstract][Full Text] [Related]
3. Fibrin exposure triggers αIIbβ3-independent platelet aggregate formation, ADAM10 activity and glycoprotein VI shedding in a charge-dependent manner.
Montague SJ; Hicks SM; Lee CS; Coupland LA; Parish CR; Lee WM; Andrews RK; Gardiner EE
J Thromb Haemost; 2020 Jun; 18(6):1447-1458. PubMed ID: 32198957
[TBL] [Abstract][Full Text] [Related]
4. Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
Stack JR; Madigan A; Helbert L; Dunne E; Gardiner EE; Andrews RK; Finan R; Smyth E; Kenny D; McCarthy GM
PLoS One; 2017; 12(11):e0188027. PubMed ID: 29141000
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet reactivity as measured by plasma glycoprotein VI in gout.
Conway R; Murphy CL; Madigan A; Kavanagh P; Geraghty L; Redmond N; Helbert L; Carey JJ; Dunne E; Kenny D; McCarthy GM
Platelets; 2018 Dec; 29(8):821-826. PubMed ID: 29090618
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
Trevillyan JM; Gardiner EE; Andrews RK; Maisa A; Hearps AC; Al-Tamimi M; Crowe SM; Hoy JF
Platelets; 2017 May; 28(3):301-304. PubMed ID: 27848272
[TBL] [Abstract][Full Text] [Related]
7. Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels.
Al-Tamimi M; Tan CW; Qiao J; Pennings GJ; Javadzadegan A; Yong AS; Arthur JF; Davis AK; Jing J; Mu FT; Hamilton JR; Jackson SP; Ludwig A; Berndt MC; Ward CM; Kritharides L; Andrews RK; Gardiner EE
Blood; 2012 May; 119(18):4311-20. PubMed ID: 22431567
[TBL] [Abstract][Full Text] [Related]
8. IgG fractions from patients with antiphospholipid syndrome and systemic lupus erythematosus bind to platelets, but do not affect collagen-induced platelet activation.
Ho YC; Brake SJ; Ahuja K; Acott N; Tiao J; Baker R; Adams MJ
Biotech Histochem; 2022 Nov; 97(8):604-615. PubMed ID: 35394397
[TBL] [Abstract][Full Text] [Related]
9. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.
Montague SJ; Delierneux C; Lecut C; Layios N; Dinsdale RJ; Lee CS; Poulter NS; Andrews RK; Hampson P; Wearn CM; Maes N; Bishop J; Bamford A; Gardiner C; Lee WM; Iqbal T; Moiemen N; Watson SP; Oury C; Harrison P; Gardiner EE
Blood Adv; 2018 Feb; 2(3):240-251. PubMed ID: 29437639
[TBL] [Abstract][Full Text] [Related]
10. Properties of soluble glycoprotein VI, a potential platelet activation biomarker.
Naitoh K; Hosaka Y; Honda M; Ogawa K; Shirakawa K; Furusako S
Platelets; 2015; 26(8):745-50. PubMed ID: 25549161
[TBL] [Abstract][Full Text] [Related]
11. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
12. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI.
Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK
Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326
[TBL] [Abstract][Full Text] [Related]
13. Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI.
Inoue O; Osada M; Nakamura J; Kazama F; Shirai T; Tsukiji N; Sasaki T; Yokomichi H; Dohi T; Kaneko M; Kurano M; Oosawa M; Tamura S; Satoh K; Takano K; Miyauchi K; Daida H; Yatomi Y; Ozaki Y; Suzuki-Inoue K
Int J Hematol; 2019 Sep; 110(3):285-294. PubMed ID: 31165998
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.
Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N
Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
Pennings GJ; Yong AS; Wong C; Al-Tamimi M; Gardiner EE; Andrews RK; Kritharides L
Platelets; 2014; 25(8):639-42. PubMed ID: 24245520
[TBL] [Abstract][Full Text] [Related]
16. GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion.
Hosseini E; Ghasemzadeh M; Nassaji F; Jamaat ZP
Platelets; 2017 Jul; 28(5):498-508. PubMed ID: 27778530
[TBL] [Abstract][Full Text] [Related]
17. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke.
Al-Tamimi M; Gardiner EE; Thom JY; Shen Y; Cooper MN; Hankey GJ; Berndt MC; Baker RI; Andrews RK
Stroke; 2011 Feb; 42(2):498-500. PubMed ID: 21193745
[TBL] [Abstract][Full Text] [Related]
18. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
Takahashi H; Moroi M
Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
[TBL] [Abstract][Full Text] [Related]
19. A-Disintegrin-And-Metalloproteinase (ADAM) 10 Activity on Resting and Activated Platelets.
Facey A; Pinar I; Arthur JF; Qiao J; Jing J; Mado B; Carberry J; Andrews RK; Gardiner EE
Biochemistry; 2016 Mar; 55(8):1187-94. PubMed ID: 26840909
[TBL] [Abstract][Full Text] [Related]
20. Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.
Pignatelli P; Pastori D; Bartimoccia S; Menichelli D; Vicario T; Nocella C; Carnevale R; Violi F
Pharmacol Res; 2016 Nov; 113(Pt A):484-489. PubMed ID: 27693274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
